Complete financial analysis of CareMax, Inc. (CMAXW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareMax, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Atea Pharmaceuticals, Inc. (AVIR) Income Statement Analysis – Financial Results
- Ashtead Group plc (ASHTF) Income Statement Analysis – Financial Results
- Ridgeline Minerals Corp. (0GC0.F) Income Statement Analysis – Financial Results
- Repsol, S.A. (REPYF) Income Statement Analysis – Financial Results
- Jilin Expressway Co., Ltd. (601518.SS) Income Statement Analysis – Financial Results
CareMax, Inc. (CMAXW)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.caremax.com
About CareMax, Inc.
CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, Tennessee, Texas, and New York. The company is headquartered in Miami, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 751.10M | 631.13M | 295.76M | 103.42M | 90.60M | 72.38M |
| Cost of Revenue | 737.20M | 550.83M | 264.31M | 83.42M | 51.62M | 44.16M |
| Gross Profit | 13.90M | 80.30M | 31.45M | 20.00M | 38.98M | 28.22M |
| Gross Profit Ratio | 1.85% | 12.72% | 10.63% | 19.34% | 43.02% | 38.99% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 80.68M | 75.82M | 40.58M | 7.75M | 11.56M | 23.53M |
| Selling & Marketing | 14.27M | 11.76M | 4.96M | 1.07M | 20.85M | 1.21M |
| SG&A | 94.96M | 87.59M | 45.53M | 8.82M | 32.41M | 24.74M |
| Other Expenses | 575.10M | 21.72M | 13.22M | 1.50M | 0.00 | 0.00 |
| Operating Expenses | 670.05M | 109.30M | 58.75M | 10.32M | 32.41M | 24.74M |
| Cost & Expenses | 1.41B | 660.13M | 323.06M | 93.74M | 84.04M | 68.90M |
| Interest Income | 0.00 | 20.24M | 4.49M | 1.66M | 720.40K | 0.00 |
| Interest Expense | 54.43M | 20.24M | 4.49M | 1.66M | 0.00 | 0.00 |
| Depreciation & Amortization | 39.31M | 21.72M | 13.22M | 1.50M | 975.90K | 602.85K |
| EBITDA | -590.46M | -15.38M | 11.19M | 11.18M | 7.54M | 4.09M |
| EBITDA Ratio | -78.61% | -1.07% | -11.80% | 10.81% | 8.32% | 5.65% |
| Operating Income | -656.15M | -29.00M | -27.30M | 9.68M | 6.57M | 3.49M |
| Operating Income Ratio | -87.36% | -4.60% | -9.23% | 9.36% | 7.25% | 4.82% |
| Total Other Income/Expenses | -28.06M | -28.34M | 22.31M | -2.11M | -720.40K | 0.00 |
| Income Before Tax | -684.21M | -57.34M | -6.52M | 7.57M | 5.85M | 3.49M |
| Income Before Tax Ratio | -91.09% | -9.09% | -2.20% | 7.32% | 6.45% | 4.82% |
| Income Tax Expense | -863.00K | -19.54M | 159.00K | 1.63M | -173.19K | 16.47K |
| Net Income | -683.35M | -37.80M | -6.68M | 5.94M | 6.02M | 3.47M |
| Net Income Ratio | -90.98% | -5.99% | -2.26% | 5.75% | 6.64% | 4.79% |
| EPS | -183.30 | -12.49 | -3.90 | 16.42 | 0.00 | 9.54 |
| EPS Diluted | -183.30 | -12.49 | -3.81 | 16.51 | 0.00 | 9.64 |
| Weighted Avg Shares Out | 3.73M | 3.03M | 1.71M | 361.95K | 0.00 | 363.66K |
| Weighted Avg Shares Out (Dil) | 3.73M | 3.03M | 1.75M | 359.87K | 0.00 | 359.87K |
Source: https://incomestatements.info
Category: Stock Reports